Entero Healthcare Ltd - Consolidation Engine Gains Momentum - Company Update
Entero Healthcare reported a strong Q4FY26, with revenue and earnings ahead of our estimates, driven by healthy organic growth and acquisition-led scale-up. The co. continued to outperform IPM at 1.4x, supported by its pan-India distribution platform, wider manufacturer relationships and growing wallet share across pharma and healthcare products. FY26 was also a year of strong execution, with Entero delivering on its stated guidance of 4.0% EBITDA margin and positive operating cash flow of Rs 962mn, aided by better gross margins, working capital efficiencies and operating leverage. Further, the company’s strategic expansion into MedTech is gaining meaningful scale, with MedTech revenues expected to cross Rs 10bn in FY27e, while also supporting margin accretion given the higher commercial role played by Entero in this segment. While we maintain our revenue estimates, we revise our margin assumptions upwards; however, our PAT after MI estimates is lowered due to higher than estimated minority interest. We maintain our positive stance though lower our rating to ACCUMULATE with revised TP at Rs 1,440.
Entero Healthcare Ltd. Stock Price Chart
Robust revenue growth:
Entero reported robust revenue growth of 42.6% YoY to Rs 19.1bn (MNCL Est- Rs 17.8bn) in Q4FY26, driven by healthy organic growth and acquisition-led consolidation. Organic growth stood at 16.6% YoY, while new acquisitions contributed 26.0% to growth during the quarter. On a like-for-like basis, revenue grew 43.1% YoY, with the company continuing to outperform IPM at 1.4x. During the year, the company closed seven acquisitions, including three in MedTech, which has now become a meaningful growth lever. For FY27, management has guided 23% revenue growth, excluding any new acquisitions, driven by calendarization benefits of FY26 acquisitions and continued organic momentum across pharma and MedTech.
Best-ever Margins:
Entero reported its best-ever margin performance in Q4FY26, with gross margins expanding by 109bps YoY to 10.9%, driven by better product mix, procurement efficiencies and higher contribution from commercial-role businesses. OPM improved by 85bps YoY to 4.5%, aided by higher gross margins and lower employee expenses (-50bps YoY), partially offset by higher other expenses (+75bps YoY). EBITDA grew 75.9% YoY to Rs 860mn (MNCL Est- Rs 746mn), led by strong revenue growth, margin expansion and operating leverage benefits. Reported PAT grew 43.6% YoY to Rs 451mn (MNCL Est- Rs 432mn); however, adjusted PAT stood at Rs 281mn, up 9.0% YoY, impacted by elevated minority interest. The higher minority interest was due to abnormal contribution from one partially owned subsidiary in Q4FY26, while the management expects to normalise in FY27. For FY26, Entero achieved its guided 4.0% EBITDA margin, while the management has guided for further improvement to 5.0% in FY27, supported by MedTech scale-up, low-margin business rationalisation and operating efficiencies.
Outlook
Entero delivered a strong FY26, meeting its guidance on both 4.0% EBITDA margin and positive OCF of Rs 962mn, supported by margin expansion and working capital efficiencies. Working capital improvement was aided by better operating discipline and higher trade payables, largely driven by the rising contribution of MedTech, where vendor credit periods are longer than pharma distribution. We remain positive on Entero’s consolidation-led model and MedTech scale-up, which should support FY27E growth and margins. However, FY28E growth could moderate as the base becomes larger and acquisition-led contribution normalises. We maintain our revenue estimates for FY27E/FY28E, while revising margin assumptions upwards, supported by better MedTech performance and an improved overall product mix. Accordingly, our reported PAT estimates move higher; however, PAT after minority interest is revised lower versus our earlier estimates, as we factor in a higher contribution from minority-owned subsidiaries.
Valuation and key risk:
We factor in Revenue/EBITDA/ PAT after MI CAGR of 20%/36%/48% over FY26–28E, led by organic growth, MedTech scale-up and margin expansion. While FY27E growth should remain healthy, FY28E growth could moderate as acquisition-led contribution normalises. We maintain our revenue estimates, revise margin assumptions upwards, but lower Adj. PAT estimates due to higher minority interest. We value Entero at 25x FY28E EPS, arriving at a revised TP of Rs 1,440 (vs. Rs 1,435 earlier), and lower our rating to ACCUMULATE (vs. BUY earlier) on back of sharp-run in the last 6-months. Key risks: Slower organic growth, acquisition integration challenges, higher minority interest, working capital deterioration and slower MedTech ramp-up.
Company website: https://www.enterohealthcare.com/
| Rating | ACCUMULATE |
|---|---|
| CMP* | INR 1,280 |
| Target Price | INR 1,440 |
| Upside | 13% |
*CMP is as per report published date
Click to download the full Entero Healthcare Ltd Q4FY26 Company Update
Analyst:
- Rahul Dani - Research Analyst, Institutional Equities (NISM-201500034725)
- Riya Shah - Research Associate, Institutional Equities (NISM-201800191080)
FAQs on Entero Healthcare Ltd Q4FY26 Company Update
These FAQs summarize key insights from MNCL’s institutional equity research on Entero Healthcare, highlighting performance trends, growth drivers and key risks.
1. What drove Entero Healthcare’s Q4FY26 growth?
Growth was supported by healthy organic expansion, acquisition-led consolidation and rising contribution from the MedTech business.
2. How did margins improve in Q4FY26?
Margins improved due to better product mix, procurement efficiencies, operating leverage and higher contribution from commercial-role businesses.
3. Why is MedTech important for Entero Healthcare?
MedTech offers higher growth potential, stronger margins and longer vendor credit periods, supporting profitability and working capital efficiency.
4. What is the company’s FY27 outlook?
Management expects healthy revenue growth and further EBITDA margin improvement supported by acquisition integration and MedTech scale-up.
5. What are the key risks for Entero Healthcare?
Key risks include slower organic growth, acquisition integration challenges, higher minority interest and slower-than-expected MedTech expansion.
Before You Trade, Strengthen Your Foundations with These Guides
- For a stronger understanding of indicators such as RSI, VWAP, and trendlines, check our 👉 Technical Analysis Fundamentals section.
- Want to refine your risk-reward planning? Explore our insights on 👉 Position Sizing & Risk Management Strategies.
Disclaimer: - Investments in securities market are subject to market risk, read all the related document carefully before investing. https://www.mnclgroup.com/research-disclaimer
Latest Companies Updates
Archives
- February 2024
- October 2024
- November 2024
- December 2024
- February 2025
- March 2025
- April 2025
- May 2025
- June 2025
- July 2025
- August 2025
- September 2025
- October 2025
- November 2025
- December 2025
- January 2026
- March 2026
- February 2026
- April 2026
- May 2026
- June 2026
- July 2026
- August 2026
- September 2026
- October 2026
Related Blog
FIEM Industries - Riding the tailwinds of 2W boom | Q1FY27 Company Update
Jubilant Agri & Consumer Products Ltd. - Strong Quarter; Sticking to Continued Growth Trajectory | Q1FY27 Company Update
Landmark Cars - Growth intact; After-sales ramp-up to drive the next leg | Q1FY27 Company Update
TD Power Systems Ltd - Powering ahead on AI and export momentum | Q1FY27 Company update
Ecos Mobility Ltd - Strong business growth; but margin pressure persists | Q1FY27 Company Update
ESAB India Ltd - Healthy growth, sharper margins | Q1FY27 Company Update
Borosil Ltd - From capacity build-out to earnings growth | Q1FY27 Company Update
KSB Ltd - Transient Pause in Growth, Recovery Ahead | Q1FY27 Company update
Minda Corporation - Solid execution | Q1FY27 Company Update
Scoda Tubes - Muted Performance | Q1FY27 Company Update
IFGL Refractories - Domestic muted; overseas subsidiaries shine | Q1FY27 Company Upda
Triveni Turbine Ltd - Margins stumble; exports accelerate; H2 recovery remains | Q1FY27 Company update
Carysil Ltd - Scaling up growth; Earnings outlook strengthens | Q1FY27 Company Update
Venus Pipes & Tubes - In-line performance | Q1FY27 Company Update
Godawari Power & Ispat - Project Delays | Q1FY27 Company Update
Goldiam International Ltd - Strong B2B Execution; ORIGEM expansion turns calibrated | Q1FY27 Company Update
Travel Food Services Ltd - A long runway for growth | Q1FY27 Company Update
Entero Healthcare Ltd - Organic growth takes centre stage; margin expansion accelerates | Q1FY27 Company Update
Cello World - Steel & Glassware ramp-up key to revival | Q1FY27 Company Update
JNK India Ltd - Diversification provides improved growth visibility | Q1FY27 Company Update
Saksoft Ltd - Broadly in-line; maintain buy | Q1FY27 Company Update
SJS Enterprises Ltd - In-line Performance | Q1FY27 Company Update
RHI Magnesita India - Excellent Performance | Q1FY27 Company Update
Viyash Scientific Ltd - Formulations drive robust growth | Q1FY27 Company Update
Vesuvius India Ltd - Another weak quarter | 2QCY26 Company Update
La Opala RG - Cautiously optimistic | Q1FY27 Company Update
Ratnamani Metals & Tubes Ltd - Weak Quarter | Q1FY27 Company Update
Mrs Bectors Food - Strong quarter; Baking Multi-Year Growth | Q1FY26 Company Update
Kirloskar Ferrous Industries Ltd. - Navigating challenging times | Q1FY27 Company Update
The Anup Engineering Ltd. - Not Out of the Woods Yet | Q1FY27 Company Update
Mayur Uniquoters - Export Momentum Accelerates | Q1FY27 Company Update
Sundram Fasteners Ltd - Export recovery surprises positively | Q1FY27 Company Update
R Systems - Stable Quarter | Q2CY26 Company Update
Rashi Peripherals - Another record quarter | Q1FY27 Company Update
ASK Automotive Ltd. - New business addition drives re-rating | Q1FY26 Company Update
Wonderla Holidays - Chennai Strengthens Medium-Term Visibility | Q1FY27 Company Update
Happy Forgings Ltd - On a high growth trajectory; fairly priced | Q1FY27 Company Update
Inox India Ltd - Looking beyond a soft quarter; growth acceleration ahead | Q1FY27 Company update
Ethos Ltd. - Expanding reach, elevating the mix | Q1FY27 Company Update
Sri Lotus Developers and Realty - Robust Presales; Luxury redevelopment Momentum Gathers Pace | Q1FY27 Company Update
Pricol Ltd - Large business additions drive re-rating | Q1FY27 Company update
Aditya Vision Ltd - Scaling beyond core markets | Q1FY27 Company Update
Indegene Ltd - Broadly in-line; maintain buy | Q1FY27 Company Update
Redington Ltd - All-round beat | Q1FY27 Company update
Netweb Technologies India Ltd - AI systems drive growth; margins beat estimate | Q1FY27 Company update
Ivalue Infosolutions - Stable set in a seasonally weak quarter | Q1FY27 Company Update
Aurionpro solutions Ltd - Another subdued quarter | Q1FY27 Company Update
INOX India Ltd - FY26 Annual Report Analysis - Record FY26, Acceleration Ahead
Kirloskar Pneumatic - Slow start to the new fiscal | Company Update
TD Power Systems Ltd - FY26 Annual Report Analysis - Positive Readthrough | Company Update
Jubilant Agri & Consumer Products ltd. -Scaling Up for the Next Growth Cycle - Company Update
The Anup Engineering - Middle East Crisis Clouds Near-Term Outlook - Company Update
IFGL Refractories Ltd. - Domestic muted; overseas subsidiaries shine - Company Update
FIEM Industries Ltd. - Strong Execution and Margin Resilience - Company Update
La Opala RG - Near term pain, recovery building - Company Update
RHI Magnesita India Ltd. - Tough quarter; Price hikes to the rescue - Company Update
Ecos Mobility Ltd - Well-positioned to drive India's corporate mobility growth - Company Update
Mrs Bectors Food - Short-term headwinds; long term growth intact- Company Update
Cello World - Capacity ramp-up key to recovery - Company Update
Scoda Tubes Ltd. - Poor performance; Chasing strong recovery - Company Update
Goldiam International - B2B Cash cow, ORIGEM the next growth engine - Company Update
Landmark Cars - Consolidation to drive profitable growth - Company Update
Travel Food Services Ltd - Premiumization-led growth - Company Update
Saksoft Ltd - Weakness across top clients drags earnings - Company Update
Entero Healthcare Ltd - Consolidation Engine Gains Momentum - Company Update
Viyash Scientific Ltd. - Sustains high margins, focus on new growth avenues - Company Update
JNK India Ltd. - Growth visibility strengthens - Company Update
Godawari Power & Ispat Ltd. - Excellent performance - Company Update
Carysil Ltd - Expanding capacity, deepening global partnerships - Company Update
Ratnamani Metals and Tubes Ltd. - Recovery in sight - Company Update
Triveni Turbine Ltd. - Growth in Exports and Aftermarket keeps Outlook Healthy - Company update
TD Power Systems - Robust quarter; Large Generator Bet Strengthens Outlook | Company update
Rashi Peripherals Ltd - Stellar all-round performance | Company Update
Sri Lotus Developers and Realty Ltd - Robust presales; luxury demand driving outperformance - Company update
Kirloskar Ferrous Industries - Pricing power yet to fully reflect in spreads | Company Update
Vesuvius India Ltd. - Weak quarter; Analyst Meet KTA - Company Update
R Systems International Ltd - Margins shine; growth to rebound - Company update
SJS Enterprises Ltd - Premiumisation and Export-led Outperformance - Company Update
KSB Ltd. - Q1CY26 PAT trails sales; margins bite - Company Update
Sri Lotus Developers and Realty Ltd. ─ Strong Outlook, Relentless Focus on Growth | Q4FY26 Company Update
Vesuvius India Ltd. - Subdued quarter | Company update
Kirloskar Ferrous Industries - Shutdown and pricing weakness spoil the show | Company Update
Goldiam International - From export strength to domestic scale - Company Update
Ratnamani Metals and Tubes Ltd.: Core pipes weak; subsidiaries anchor margins - Company Update
Carysil Ltd: Crafting the future of modern kitchens - Company Update
Wonderla Holidays: Chennai Takes The Baton As Mature Parks Plateau - Company Update
Rashi Peripherals Ltd: Stellar quarter - Company Update
Triveni Turbine: Worst likely behind, recovery pending - Company update
The Anup Engineering: Through the Trough, Recovery in the offing - Company Update
Saksoft Ltd: Temporary headwinds, normalization in sight - Company Update
Mayur Uniquoters: Riding export momentum - Company Update
Scoda Tubes Ltd.: Slight miss; structural thesis intact - Company Update
TD Power Systems: Global demand fuelling growth visibility - Company Update
SJS Enterprises Ltd - Premiumisation and Export-led Outperformance - Company Update
Sundram Fasteners Ltd.: Exports spoil the show - Company Update
ASK Automotive Ltd. - Firing on all cylinders - Company Update
Kirloskar Ferrous Ind. - Casting and tubes outperform, spreads spoil the show | Company Update
IFGL Refractories Ltd. - Domestic focus continues to payoff; overseas improving gradually | Company Update
Borosil Ltd. - Glassware ignites growth; levers to power margins | Company Update
Venus Pipes & Tubes Ltd. - Export and welded drives confidence | Company Update
ESAB India - Encouraging quarter; growth in focus | Company Update
The Anup Engineering - All eyes on cash conversion | Company Update
Rashi Peripherals Ltd – Turns cashflow positive
Wonderla Holidays - Chennai on Track; Expansion Visibility Low | MNCL Research Update
R Systems International - Strong growth tempered by higher SG&A & RSU costs | MNCL Research Update
SJS Enterprises Ltd - Designed to outperform | MNCL Research Update
Channel checks - Opalware and Glassware - Borosil Sets the Benchmark in Opalware Retail
Goldiam International - LGD Momentum builds; ORIGEM scaling | Company Update
ASK Automotive Ltd – Meets Expectations; ALPS & Aftermarket to Drive Growth | MNCL Research Company Update
Sundram Fasteners Ltd. - Steady Domestic Momentum Offsets Export Weakness; upgrade to Accumulate - Company Update
JNK India Ltd – End of Overhang, Execution to Drive Growth | Q2FY26



